Peer Review reports
From: Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
| Original Submission | ||
|---|---|---|
| 19 Nov 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 10 Dec 2021 | Reviewed | Reviewer Report - Behailu Terefe Tesfaye |
| 28 Mar 2022 | Reviewed | Reviewer Report - Nashwa Masnoon |
| 27 May 2022 | Author responded | Author comments - Dallas P. Seitz |
| Resubmission - Version 3 | ||
| 27 May 2022 | Submitted | Manuscript version 3 |
| 31 May 2022 | Author responded | Author comments - Dallas P. Seitz |
| Resubmission - Version 4 | ||
| 31 May 2022 | Submitted | Manuscript version 4 |
| 3 Jun 2022 | Reviewed | Reviewer Report - Behailu Terefe Tesfaye |
| 10 Jun 2022 | Reviewed | Reviewer Report - Nashwa Masnoon |
| 17 Jun 2022 | Author responded | Author comments - Dallas P. Seitz |
| Resubmission - Version 5 | ||
| 17 Jun 2022 | Submitted | Manuscript version 5 |
| Publishing | ||
| 6 Jul 2022 | Editorially accepted | |
| 19 Jul 2022 | Article published | 10.1186/s12877-022-03279-x |
You can find further information about peer review here.